Literature DB >> 14557921

Pulmonary Mycobacterium xenopi infection in AIDS patients treated with HAART in Hungary.

J Szlávik1, C Sárvári.   

Abstract

Reported here are three cases of pulmonary Mycobacterium xenopi infection that occurred in AIDS patients in Hungary shortly after starting highly active antiretroviral therapy. In this country, Mycobacterium xenopi is the most common nontuberculous mycobacterial species causing pulmonary mycobacterial infections. Cases of pulmonary Mycobacterium xenopi disease have been described in patients infected with the human immunodeficiency virus infection and in patients with other immunodeficiencies; however, only limited information is currently available concerning the connection between nontuberculous Mycobacterium infection and AIDS in Hungary. This report thus adds useful information regarding the diagnosis, clinical course, and treatment regimens of Mycobacterium xenopi infections in AIDS patients.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14557921     DOI： 10.1007/s10096-003-1018-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  11 in total

Review 1.  Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy.

Authors:  W J Burman; B E Jones
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

Review 2.  Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

3.  A strain of Mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis, and its relation to atypical acid-fast bacilli occurring in man.

Authors:  H SCHWABACHER
Journal:  J Hyg (Lond)       Date:  1959-03

Review 4.  Nosocomial infections due to nontuberculous mycobacteria.

Authors:  M S Phillips; C F von Reyn
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

5.  Nontubercular mycobacterial pulmonary infection in immunocompetent men.

Authors:  N Kanathur; H N Shantaveerapa; R P Byrd; J B Mehta; T M Roy
Journal:  South Med J       Date:  2001-07       Impact factor: 0.954

6.  Mycobacterium xenopi infection in patients with human immunodeficiency virus infection.

Authors:  P el-Helou; A Rachlis; I Fong; S Walmsley; A Phillips; I Salit; A E Simor
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

7.  Mycobacterium xenopi: innocent bystander or emerging pathogen?

Authors:  T M Jiva; H M Jacoby; L A Weymouth; D A Kaminski; A C Portmore
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

Review 8.  [Mycobacterium xenopi: epidemiological and bacteriological features].

Authors:  J N Dauendorffer; C Laurain; M Weber; M Dailloux
Journal:  Ann Biol Clin (Paris)       Date:  2001 Mar-Apr       Impact factor: 0.459

9.  Mycobacterium xenopi in HIV-infected patients: an emerging pathogen.

Authors:  N P Juffermans; A Verbon; S A Danner; E J Kuijper; P Speelman
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

10.  Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients.

Authors:  A A El-Solh; J Nopper; M R Abdul-Khoudoud; S M Sherif; A T Aquilina; B J Grant
Journal:  Chest       Date:  1998-07       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.